Informatie:
Fout:
ID
28392
Beschrijving
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00512083
Link
https://clinicaltrials.gov/show/NCT00512083
Trefwoorden
Versies (3)
- 29-06-17 29-06-17 -
- 10-01-18 10-01-18 - Julian Varghese
- 10-01-18 10-01-18 - Julian Varghese
Houder van rechten
Antisoma Research
Geüploaded op
10 januari 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Leukemia, Myeloid NCT00512083
Eligibility Leukemia, Myeloid NCT00512083
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia, Myeloid NCT00512083
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Primary refractory or relapsed aml
Item
primary refractory or relapsed aml
boolean
C0278780 (UMLS CUI [1])
Confirmed diagnosis aml
Item
confirmed diagnosis of aml (de novo or secondary) as defined by who classification
boolean
C0023467 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
Age
Item
aged at least 18 years
boolean
C0001779 (UMLS CUI [1])
Acute Promyelocytic Leukemia
Item
initial diagnosis of acute promyelocytic leukemia as defined by french-american-british criteria (bennett 1976)
boolean
C0023487 (UMLS CUI [1])
Blast crisis stage of chronic myeloid leukemia
Item
patient in blast crisis stage of chronic myeloid leukemia
boolean
C0919644 (UMLS CUI [1])
High-dose cytarabine
Item
received high-dose cytarabine (total cumulative dose of >6g/m sq)in last 6 months
boolean
C0010711 (UMLS CUI [1])
Interval first onset of last complete remission and current relapse
Item
interval of <6 months between first onset of last complete remission and current relapse
boolean
C0677874 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C0035020 (UMLS CUI [1,2])
Primary refractory leukemia
Item
those with primary refractory leukemia who have received more than three previous induction cycles
boolean
C0857127 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
Relapsed patients, more than three previous treatment regimens
Item
relapsed patients who have received more than three previous treatment regimens
boolean
C0392920 (UMLS CUI [1])